All stories tagged :

Pr Newswire

HUTCHMED Highlights HMPL-A251 Data Presented at the AACR-NCI-EORTC International Conference on...

Tháng 10 23

Biomea Fusion to Participate in Citi’s SMID Biotech C-Suite Fireside Chat...

1 ngày ago

Supernus Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host...

1 ngày ago

Jushi Holdings Inc. to Report Third Quarter 2025 Financial Results on...

1 ngày ago

STERIS to Host a Conference Call for Fiscal 2026 Second Quarter...

1 ngày ago

CLIQ MC Sets the Standard for Google Ads Performance Across Australia

1 ngày ago

Appian Partners with Wotton Kearney to Transform Claims and Reporting Management...

1 ngày ago

LNG2026 Unveils Plenary Sessions and First-Round Speakers

1 ngày ago

Dreamegg Unveils Sunrise 1+: The Next Generation Sunrise Alarm Clock for...

1 ngày ago

Gushine Electronics Officially Inaugurates Hai Phong Lithium Battery Manufacturing Base in...

1 ngày ago

Notice convening an Extraordinary General Meeting of Novo Nordisk A/S

2 ngày ago

1 2 3 4 5 6 … 776 777 778 Page 3 of 778

Featured

Vor Bio to Host Webcast on Late-Breaking China Phase 3 Telitacicept...

4 giờ ago

6 Energy-Saving Tips

4 giờ ago

Saudia Unveils SV Lifestyle Brand at Riyadh Fashion Week

4 giờ ago

All Star Digital and Dart Co Launch One Hitters: Exclusive Partnership...

4 giờ ago

4 giờ ago

Vor Bio to Host Webcast on Late-Breaking China Phase 3 Telitacicept...

CAMBRIDGE, Mass., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, announced today that it will host a live webcast to present and discuss the newly disclosed, late-breaking 48-week Phase 3 clinical data in China for...